FDA WARNING_LETTER - Diamond B Dairy - January 17, 2014
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
On January 10, 16, and 17, 2014, the FDA inspected a dairy operation in Wendell, Idaho, and found violations of the Federal Food, Drug, and Cosmetic Act. The operation sold a cow for slaughter on July 25, 2013, which was found to have 24.73 ppm of sulfamethazine in its kidney tissue, exceeding the 0.1 ppm tolerance for uncooked cattle tissues. This drug is not approved for use in lactating dairy cows, making the food adulterated under section 402(a)(2)(C)(ii) of the FD&C Act.
The investigation also revealed insanitary conditions, specifically a failure to maintain complete treatment records, indicating that medicated animals with harmful drug residues could enter the food supply, thus adulterating food under section 402(a)(4) of the FD&C Act.
Furthermore, the new animal drug Supra Sulfa III (sulfamethazine) Boluses, NADA 120-615, was adulterated because it was used extralabelly on a lactating dairy cow, which is prohibited by 21 C.F.R. 530.41(a)(9). This use was not by or on the order of a licensed veterinarian within a valid veterinarian/client/patient relationship, causing the drug to be unsafe under section 51
- Office
- Seattle District Office
- Person
ID · c628a797-1949-4d0c-8a19-2cd07a3664ad
Full citation text and observation details available on the Dashboard.